625 related articles for article (PubMed ID: 17020457)
1. Monoclonal antibodies in chronic lymphocytic leukemia.
Ferrajoli A; Faderl S; Keating MJ
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
[TBL] [Abstract][Full Text] [Related]
2. Newer monoclonal antibodies for hematological malignancies.
Castillo J; Winer E; Quesenberry P
Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
[TBL] [Abstract][Full Text] [Related]
3. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
Ahmadi T; Schuster SJ
J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
[No Abstract] [Full Text] [Related]
4. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
Del Poeta G; Ilaria Del Principe M; Buccisano F; Maurillo L; Niscola P; Venditti A; Amadori S
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1787-800. PubMed ID: 17181492
[TBL] [Abstract][Full Text] [Related]
5. Management of advanced chronic lymphocytic leukemia.
Cao TM; Coutre SE
Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody therapy of chronic lymphocytic leukemia.
Mavromatis B; Cheson BD
J Clin Oncol; 2003 May; 21(9):1874-81. PubMed ID: 12721266
[TBL] [Abstract][Full Text] [Related]
7. Alemtuzumab in chronic lymphocytic leukemia.
James DF; Kipps TJ
Future Oncol; 2007 Feb; 3(1):29-42. PubMed ID: 17280499
[TBL] [Abstract][Full Text] [Related]
8. High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
Dungarwalla M; Evans SO; Riley U; Catovsky D; Dearden CE; Matutes E
Haematologica; 2008 Mar; 93(3):475-6. PubMed ID: 18310545
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in chronic lymphocytic leukemia.
Jaglowski SM; Byrd JC
Semin Hematol; 2010 Apr; 47(2):156-69. PubMed ID: 20350663
[TBL] [Abstract][Full Text] [Related]
10. Bendamustine in chronic lymphocytic leukemia and refractory lymphoma.
Rummel MJ
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S7-10. PubMed ID: 18760709
[TBL] [Abstract][Full Text] [Related]
11. State of the art treatment of chronic lymphocytic leukaemia.
Hallek M; Pflug N
Blood Rev; 2011 Jan; 25(1):1-9. PubMed ID: 21095047
[TBL] [Abstract][Full Text] [Related]
12. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
13. Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Tsimberidou AM; Wierda WG; Plunkett W; Kurzrock R; O'Brien S; Wen S; Ferrajoli A; Ravandi-Kashani F; Garcia-Manero G; Estrov Z; Kipps TJ; Brown JR; Fiorentino A; Lerner S; Kantarjian HM; Keating MJ
J Clin Oncol; 2008 Jan; 26(2):196-203. PubMed ID: 18182662
[TBL] [Abstract][Full Text] [Related]
14. Therapy of chronic lymphocytic leukaemia.
Hallek M
Best Pract Res Clin Haematol; 2010 Mar; 23(1):85-96. PubMed ID: 20620973
[TBL] [Abstract][Full Text] [Related]
15. Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
Byrd JC; Lin TS; Grever MR
Semin Oncol; 2006 Apr; 33(2):210-9. PubMed ID: 16616068
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody therapy of chronic lymphocytic leukaemia.
Cheson BD
Best Pract Res Clin Haematol; 2010 Mar; 23(1):133-43. PubMed ID: 20620977
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.
Goodrich A
Clin J Oncol Nurs; 2007 Feb; 11(1 Suppl):23-36. PubMed ID: 17474175
[TBL] [Abstract][Full Text] [Related]
18. Current status and future directions of clinical trials in chronic lymphocytic leukemia.
Nerenstone SR; Archer JI; Cheson BD
Oncology (Williston Park); 1987 Oct; 1(8):31-40, 44. PubMed ID: 3079490
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic lymphocytic leukemia.
Faderl SJ; Keating MJ
Curr Hematol Rep; 2005 Jan; 4(1):31-8. PubMed ID: 15610657
[TBL] [Abstract][Full Text] [Related]
20. Novel therapeutic strategies with alemtuzumab for chronic lymphocytic leukemia.
Rai KR
Semin Oncol; 2006 Apr; 33(2 Suppl 5):S15-22. PubMed ID: 16720199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]